Wolverine Trading, LLC Amylyx Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.65 - $3.24 $6,435 - $12,636
-3,900 Reduced 18.75%
16,900 $54,000
Q2 2024

Aug 14, 2024
SELL
$1.62 - $2.71 $24,624 - $41,192
-15,200 Reduced 42.22%
20,800 $39,000
Q1 2024

May 15, 2024
BUY
$2.71 - $19.57 $59,349 - $428,583
21,900 Added 155.32%
36,000 $102,000
Q4 2023

Feb 14, 2024
BUY
$12.07 - $18.46 $170,187 - $260,286
14,100 New
14,100 $207,000

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $310M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email